238 related articles for article (PubMed ID: 20184585)
1. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
[TBL] [Abstract][Full Text] [Related]
2. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
Sellheyer K; Krahl D
Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
[TBL] [Abstract][Full Text] [Related]
3. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and β-catenin.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jun; 162(6):1294-301. PubMed ID: 20105172
[TBL] [Abstract][Full Text] [Related]
5. Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath?
Sellheyer K; Krahl D
J Cutan Pathol; 2011 Jul; 38(7):551-9. PubMed ID: 21366662
[TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
7. Trichogerminoma.
Tellechea O; Reis JP
Am J Dermatopathol; 2009 Jul; 31(5):480-3. PubMed ID: 19542926
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelioma of Pinkus is a true basal cell carcinoma developing in association with a newly identified tumour-specific type of epidermal hyperplasia.
Sellheyer K; Nelson P; Kutzner H
Br J Dermatol; 2012 Jan; 166(1):88-97. PubMed ID: 21910710
[TBL] [Abstract][Full Text] [Related]
9. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
10. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
12. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
Vidal VP; Ortonne N; Schedl A
J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
Tran TA; Muller S; Chaudahri PJ; Carlson JA
J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
[TBL] [Abstract][Full Text] [Related]
15. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
16. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
17. For Valentine's Day: adnexal induction over dermatofibroma.
Kacerovska D; Michal M; Kazakov DV
Int J Surg Pathol; 2009 Dec; 17(6):452-3. PubMed ID: 19828594
[No Abstract] [Full Text] [Related]
18. High-grade trichoblastic carcinosarcoma.
Kazakov DV; Vittay G; Michal M; Calonje E
Am J Dermatopathol; 2008 Feb; 30(1):62-4. PubMed ID: 18212548
[TBL] [Abstract][Full Text] [Related]
19. Skin-type adnexal tumor with trichoblastic germinative differentiation in the breast: a case report.
Gököz O; Presenti L; Gambacorta G; Zolfanelli F; Tricarico R; Nistri R; Baroni G; Bianchi S; Massi D
Int J Surg Pathol; 2011 Aug; 19(4):527-33. PubMed ID: 19468034
[TBL] [Abstract][Full Text] [Related]
20. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]